PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+14.4%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$75.6M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.03M |
| 2 |
Broadcom
AVGO
|
$3.21M |
| 3 |
Tesla
TSLA
|
$2.65M |
| 4 |
Viking Therapeutics
VKTX
|
$1.64M |
| 5 |
Texas Instruments
TXN
|
$1.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
$27.3M |
| 2 |
Danaher
DHR
|
$16.8M |
| 3 |
Amgen
AMGN
|
$12.2M |
| 4 |
Gilead Sciences
GILD
|
$9.54M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$7.75M |
Sector Composition
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sherwin-Williams
SHW
$92.9B
| $1.39M | 0.09% |
6,205
+3,581
| +136% | +$805K |
|
|
BPMC
202
DELISTED
Blueprint Medicines
BPMC
| $1.38M | 0.09% |
30,600
+22,502
| +278% | +$1.01M |
|
203
Vir Biotechnology
VIR
$732M
| $1.38M | 0.09% |
59,099
+45,932
| +349% | +$1.07M |
|
|
KRTX
204
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.37M | 0.08% |
+7,536
| New | +$1.37M |
|
205
WEC Energy
WEC
$34.7B
| $1.37M | 0.08% |
14,413
-466
| -3% | -$44.2K |
|
206
Coterra Energy
CTRA
$18.3B
| $1.36M | 0.08% |
55,594
+7,012
| +14% | +$172K |
|
207
Travere Therapeutics
TVTX
$1.93B
| $1.36M | 0.08% |
+60,529
| New | +$1.36M |
|
208
Morgan Stanley
MS
$236B
| $1.36M | 0.08% |
15,503
-681
| -4% | -$59.8K |
|
209
TG Therapeutics
TGTX
$5.11B
| $1.36M | 0.08% |
+90,404
| New | +$1.36M |
|
210
Alnylam Pharmaceuticals
ALNY
$59.2B
| $1.36M | 0.08% |
6,770
-6,954
| -51% | -$1.39M |
|
211
Relay Therapeutics
RLAY
$710M
| $1.36M | 0.08% |
+82,311
| New | +$1.36M |
|
212
Exact Sciences
EXAS
$10.2B
| $1.35M | 0.08% |
19,946
+127
| +0.6% | +$8.61K |
|
213
Novo Nordisk
NVO
$245B
| $1.35M | 0.08% |
16,944
+1,294
| +8% | +$103K |
|
214
Ardelyx
ARDX
$1.57B
| $1.35M | 0.08% |
+281,411
| New | +$1.35M |
|
215
Intellia Therapeutics
NTLA
$1.29B
| $1.35M | 0.08% |
36,138
+24,603
| +213% | +$917K |
|
216
Union Pacific
UNP
$131B
| $1.35M | 0.08% |
6,690
+317
| +5% | +$63.8K |
|
217
S&P Global
SPGI
$164B
| $1.35M | 0.08% |
3,904
-182
| -4% | -$62.7K |
|
218
ServiceNow
NOW
$190B
| $1.34M | 0.08% |
2,888
+594
| +26% | +$276K |
|
219
Verizon
VZ
$187B
| $1.34M | 0.08% |
34,504
-28,893
| -46% | -$1.12M |
|
220
Arrowhead Research
ARWR
$4.02B
| $1.34M | 0.08% |
52,802
+34,803
| +193% | +$884K |
|
221
BioMarin Pharmaceuticals
BMRN
$11.1B
| $1.33M | 0.08% |
13,664
-7,066
| -34% | -$687K |
|
222
Etsy
ETSY
$5.36B
| $1.33M | 0.08% |
11,918
+1,644
| +16% | +$183K |
|
223
Revolution Medicines
RVMD
$7.57B
| $1.33M | 0.08% |
+61,250
| New | +$1.33M |
|
224
Novavax
NVAX
$1.28B
| $1.31M | 0.08% |
+189,641
| New | +$1.31M |
|
|
SAGE
225
DELISTED
Sage Therapeutics
SAGE
| $1.31M | 0.08% |
+31,144
| New | +$1.31M |
|